The clinical significance of NF1 mutations in the lung adenocarcinoma sequencing studies is not reported, but reduced NF1 mRNA expression was recently found to confer both intrinsic and acquired resistance to EGFR inhibitors in another recently reported study. Here, EGFR is linked to lung adenocarcinoma.